Zymeworks Inc.
ZYME- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937653
No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Zymeworks Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 125 | 109 | −16 |
| Shares | 35.2M | 34.5M | −670.4K (−1.9%) |
| Value | $1.12B | $1.20B | +$84.0M (+7.5%) |
New holders (7)
Institutions that held Zymeworks Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen Asset Management, LLC | 70,351 | $2.44M | 0.00% |
| J. Goldman & Co LP | 67,962 | $2.36M | 0.15% |
| Picton Mahoney Asset Management | 63,225 | $2.19M | 0.08% |
| Boothbay Fund Management, LLC | 5,961 | $207.0K | 0.01% |
| Asset Dedication, LLC | 47 | $2.00K | 0.00% |
| Toronto Dominion Bank | 30 | $1.00K | 0.00% |
| Massmutual Trust Co FSB | 23 | $1.00K | 0.00% |
Sold out (23)
Institutions that held Zymeworks Inc. at the end of Q1 2021 and filed for Q2 2021 without it.